D-0829-2020 Class III Terminated
FDA drug recall D-0829-2020 was initiated by UNICHEM PHARMACEUTICALS USA INC on Jan 29, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label. The recall status is terminated (terminated Jan 8, 2021). Affected quantity: 19161600 units.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 12, 2020
- Initiation Date
- Jan 29, 2020
- Termination Date
- Jan 8, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19161600 units
Product description
Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01
Reason for recall
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.
Distribution pattern
Distributed Nationwide in the US
Code information
Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0829-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026